|
Cyclin-Dependent Kinase 8
|
D12.776.476.024.388.500 |
|
|
Mediator Complex
|
D12.776.476.024.388 |
|
|
Clofazimine
|
D002991 |
[A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)
] |
|
Retinal Dehydrogenase
|
D08.811.682.657.163.249.875 |
|
|
Clofibrate
|
D002994 |
[A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)
] |
|
Clofibric Acid
|
D002995 |
[An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
] |
|
Sodium Channel Blockers
|
D026941 |
[A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity.
] |
|
Iron-Regulatory Proteins
|
D12.776.494 |
|
|
Autophagic Cell Death
|
G04.146.954.053 |
|
|
Clofenapate
|
D002992 |
[An oral hypolipemic agent primarily used in DOGS and RATS.
] |
|
DNA Topoisomerases
|
D026942 |
[Enzymes that regulate the topology of DNA by actions such as breaking, relaxing, passing, and rejoining strands of DNA in cells. These enzymes are important components of the DNA replication system. They are classified by their substrate specificities. DNA TOPOISOMERASE I enzymes act on a single strand of DNA. DNA TOPOISOMERASE II enzymes act on double strands of DNA.
] |
|
RNA
|
D012313 |
[A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
] |
|
Sodium Chloride Symporter Inhibitors
|
D27.505.519.562.812 |
|
|
RNA Cap Analogs
|
D012314 |
[Analogs of RNA cap compounds which do not have a positive charge. These compounds inhibit the initiation of translation of both capped and uncapped messenger RNA.
] |
|
RNA Caps
|
D012315 |
[Nucleic acid structures found on the 5' end of eukaryotic cellular and viral messenger RNA and some heterogeneous nuclear RNAs. These structures, which are positively charged, protect the above specified RNAs at their termini against attack by phosphatases and other nucleases and promote mRNA function at the level of initiation of translation. Analogs of the RNA caps (RNA CAP ANALOGS), which lack the positive charge, inhibit the initiation of protein synthesis.
] |
|
Myofunctional Therapy
|
E02.760.169.063.500.727.442 |
|
|
RNA Nucleotidyltransferases
|
D012316 |
[Enzymes that catalyze the template-directed incorporation of ribonucleotides into an RNA chain. EC 2.7.7.-.
] |
|
Salmonella typhimurium
|
B03.660.250.150.710.160.760 |
|
|
RNA Phages
|
D012317 |
[Bacteriophages whose genetic material is RNA, which is single-stranded in all except the Pseudomonas phage phi 6 (BACTERIOPHAGE PHI 6). All RNA phages infect their host bacteria via the host's surface pili. Some frequently encountered RNA phages are: BF23, F2, R17, fr, PhiCb5, PhiCb12r, PhiCb8r, PhiCb23r, 7s, PP7, Q beta phage, MS2 phage, and BACTERIOPHAGE PHI 6.
] |
|
RNA Polymerase I
|
D012318 |
[A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. The enzyme functions in the nucleolar structure and transcribes DNA into RNA. It has different requirements for cations and salts than RNA polymerase II and III and is not inhibited by alpha-amanitin.
] |
